---
category: news
title: "Kiromic Announces Submission of Two IND Applications for PD1 Gamma-delta CAR - T cell Therapy with the FDA"
excerpt: "Kiromic BioPharma, a target discovery and gene-editing company utilizing artificial intelligence and its proprietary neural network platform with a therapeutic focus on immuno-oncology, announced today the submission of two investigational new drug applications with the U."
publishedDateTime: 2020-12-17T17:45:00Z
originalUrl: "https://www.nasdaq.com/press-release/kiromic-announces-submission-of-two-ind-applications-for-pd1-gamma-delta-car-t-cell"
webUrl: "https://www.nasdaq.com/press-release/kiromic-announces-submission-of-two-ind-applications-for-pd1-gamma-delta-car-t-cell"
type: article

provider:
  name: Nasdaq
  domain: nasdaq.com

topics:
  - AI in Healthcare
  - AI

secured: "X9pnaMs9d8VgnMCTFcwXY/t5NDstLZQAmVQUVvVjKCNnLAZKkaAkioi8NJMZRCm1AKQM18r4WgPIcloSLuGs4h/tKSrLZB9t36uPOn7ry3sEmkWdzFJWznWZEh0FIWo/hi7z5Y5TyZZmF8xhZ9Zc1vx2FbkHJlYNx1f4iOk/XKGfYGPenynERfBBo2C9FDW7s8pEMHgb3QcmGVLpttK9LNIPQV6QAQyYuq27JLKBDoLvllTRCTrkRfdpc/dm4WYqWc0l16AwDzIQ/m1GZTer2eo+OWgiaVp3lwM4BviiWakuJ5NOPqHHZNPm7GntpuJrksLLv9CcuNX3K72nxiCwOwhbg9MoqNl45MxqyTwQNts=;UBh38srasSCYsSEgXwyrew=="
---

